Literature DB >> 23790025

Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

Jia Wu1, Wei Zhang, Aiqiang Xu, Li Zhang, Tao Yan, Zhuo Li, Xiaopan Wu, Xilin Zhu, Juan Ma, Ke Li, Hui Li, Ying Liu.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is a common solid malignant tumor occurring worldwide that leads to the third largest cause of death compared to other cancers. Genetic and environmental factors are involved in the pathogenesis of HCC. Epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) can stimulate the proliferation of epidermal and epithelial cells. The EGF signal pathway has a relationship with the growth of the embryo, tissue repairing, and tumorigenesis.
METHODS: In this study, 416 patients with hepatitis B virus infection (HBV)-related HCC and 645 individuals who had never been infected with HBV of the Chinese Han population were enrolled. Eight single-nucleotide polymorphisms (SNPs), whose minor allele frequency >20% in the EGF and EGFR genes, were genotyped to examine their associations with hepatocarcinogenesis. Genotyping experiments were carried out using TaqMan.
RESULTS: There were significant differences in genotype distributions (p=0.005) and allele frequencies (p=0.001, odds ratio [OR]=1.43, 95% confidence interval [CI]=1.15-1.79) of rs11569017 in the EGF gene between the HCC and control groups. After binary logistic regression to determine independent factors for susceptibility to HCC under an additive model, rs11569017 was still independently associated with the susceptibility to HCC (p=0.021, OR=1.48, 95% CI=1.06-2.07), but no significant differences in other SNPs were found. Additionally, the haplotype T-G constructed by rs11569017 and rs4444903 of the EGF gene might increase the risk of HBV-related HCC (p=0.002, OR=1.44, 95% CI=1.15-1.82).
CONCLUSION: The rs11569017 T allele was associated with susceptibility to HBV-related HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790025      PMCID: PMC3732435          DOI: 10.1089/gtmb.2013.0031

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  38 in total

1.  Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis.

Authors:  Woo Sung Moon; Ho Sung Park; Ki Hoon Yu; Min Young Park; Kyung Ryoul Kim; Kyu Yun Jang; Jong Suk Kim; Baik Hwan Cho
Journal:  Hum Pathol       Date:  2006-07-27       Impact factor: 3.466

2.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 4.  Metabolism and effects of epidermal growth factor and related growth factors in mammals.

Authors:  D A Fisher; J Lakshmanan
Journal:  Endocr Rev       Date:  1990-08       Impact factor: 19.871

Review 5.  Genomics and signaling pathways in hepatocellular carcinoma.

Authors:  Augusto Villanueva; Philippa Newell; Derek Y Chiang; Scott L Friedman; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2007-02       Impact factor: 6.115

6.  Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Kenneth K Tanabe; Antoinette Lemoine; Dianne M Finkelstein; Hiroshi Kawasaki; Tsutomu Fujii; Raymond T Chung; Gregory Y Lauwers; Yakup Kulu; Alona Muzikansky; Darshini Kuruppu; Michael Lanuti; Jonathan M Goodwin; Daniel Azoulay; Bryan C Fuchs
Journal:  JAMA       Date:  2008-01-02       Impact factor: 56.272

7.  Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization.

Authors:  G I Bell; N M Fong; M M Stempien; M A Wormsted; D Caput; L L Ku; M S Urdea; L B Rall; R Sanchez-Pescador
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

Review 8.  Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer.

Authors:  Paraic A Kenny
Journal:  Expert Opin Ther Targets       Date:  2007-10       Impact factor: 6.902

9.  Liver expression of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration.

Authors:  B Mullhaupt; A Feren; E Fodor; A Jones
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

10.  Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium.

Authors:  Pallavi B Limaye; William C Bowen; Anne V Orr; Jianhua Luo; George C Tseng; George K Michalopoulos
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

View more
  12 in total

1.  Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.

Authors:  Xian-Feng Shen; Xian-Tao Zeng; Zhi-Yuan Jian; Meng Zhou; Ping Zhou; Min Zhang
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

Review 2.  The NQO1 C609T polymorphism and hepatocellular carcinoma risk.

Authors:  Yonggang Fan; Dingwen Hu; Bing Feng; Wei Wang
Journal:  Tumour Biol       Date:  2014-02-16

3.  Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.

Authors:  Guoping Jiang; Ke Yu; Lifang Shao; Xiaobo Yu; Chen Hu; Pei Qian; Haiyang Xie; Jinjun Li; Jie Zheng; Shusen Zheng
Journal:  BMC Cancer       Date:  2015-04-25       Impact factor: 4.430

4.  Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma.

Authors:  S Ma; J Wu; J Wu; Y Wei; L Zhang; Q Ning; D Hu
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

5.  Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.

Authors:  Hong-Chun Luo; Hong-Bin Zhang; Xiao-Juan Xin; Wen-Xiang Huang
Journal:  Tumour Biol       Date:  2013-12-05

6.  A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.

Authors:  Yinsheng Wang; Lidan Zha; Dan Liao; Xiaozhi Li
Journal:  Int J Genomics       Date:  2014-10-21       Impact factor: 2.326

7.  Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study.

Authors:  Kainan Li; Chen Zhong; Jun Wang; Baocheng Wang; Jun He; Jingwang Bi
Journal:  Tumour Biol       Date:  2014-09-14

8.  EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.

Authors:  Jia Wang; Yanlin Zhong; Guixia Meng
Journal:  Int J Clin Oncol       Date:  2021-07-21       Impact factor: 3.402

9.  Different frequency of epidermal growth factor rs76189946 polymorphism genotype in an Iranian colorectal cancer.

Authors:  Vahid Chaleshi; Sanaz Savabkar; Hesamodin Dolatmoradi; Mahdi Montazer Haghighi; Elmira Khalili Maryan; Sara Pasha; Narges Ebrahimi Vandfaez; Ehsan Nazemalhosseini Mojarad; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

10.  Application of a Combined Model with Autoregressive Integrated Moving Average (ARIMA) and Generalized Regression Neural Network (GRNN) in Forecasting Hepatitis Incidence in Heng County, China.

Authors:  Wudi Wei; Junjun Jiang; Hao Liang; Lian Gao; Bingyu Liang; Jiegang Huang; Ning Zang; Yanyan Liao; Jun Yu; Jingzhen Lai; Fengxiang Qin; Jinming Su; Li Ye; Hui Chen
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.